ClinicalTrials.gov
public full text
Public Domain
Calcitriol or Placebo in Men for Prostate Cancer Active Surveillance
After the diagnosis of prostate cancer, many men alter their lifestyle or diet or use various supplements in an attempt to retard the growth of their cancer. While there is limited data on the use of diet and supplements to alter the risk of prostate cancer, even less is known regarding the ability of diet or supplements to alter progression. For men who have elected active surveillance, the investigators propose to investigate the ability of vitamin D to retard the growth of prostate cancer.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Decision Navigation for Advanced Prostate Cancer Treatment Options Using mHealth#872797
- The Effects of Dietary Phosphate Intake on Calciotropic Hormones and FGF23.#874912
- Hormonal Therapy and Chemotherapy Followed by Prostatectomy in Patients With Prostate Cancer#1161543
- Fat intake after diagnosis and risk of lethal prostate cancer and all-cause mortality#643550
- Dutasteride in Enlarged Prostate Economic Assessment: A Retrospective Database Pooled Analysis of Early 5-alpha Reductase Inhibitor Use#890240
Record · ID 912094
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive